Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 3
Treatment-assignment count: 0
Stratification count: 0
Manual Review Required
CLDN18.2 expression
pancreatic cancer · Therapy Not Normalized
CLDN18.2 expression is flagged as manual review required because public trials show inclusion required evidence in 7 contexts. FDA CDx context should be reviewed manually.
Threshold snippets
Fragmentation view
Threshold count: 0
Common snippets: None extracted
Threshold label: Low
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: Low
Patent-density signal
Diagnostic appendix
Signal count: 1
Recent signals: 1
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT07024615 | https://clinicaltrials.gov/study/NCT07627711 | https://clinicaltrials.gov/study/NCT07480928 | https://clinicaltrials.gov/study/NCT06770439 | https://clinicaltrials.gov/study/NCT07066995 | https://clinicaltrials.gov/study/NCT05911217 | https://clinicaltrials.gov/study/NCT04966143